Oxford BioDynamics Plc Stock price

Equities

OBD

GB00BD5H8572

Biotechnology & Medical Research

Market Closed - London S.E. 12:35:08 2024-03-28 pm EDT 5-day change 1st Jan Change
9.4 GBX -0.95% Intraday chart for Oxford BioDynamics Plc -3.09% -66.43%
Sales 2022 154K 194K Sales 2023 510K 644K Capitalization 74.85M 94.47M
Net income 2022 -6M -7.57M Net income 2023 -10M -12.62M EV / Sales 2022 108 x
Net Debt 2022 5.14M 6.48M Net Debt 2023 1.19M 1.5M EV / Sales 2023 149 x
P/E ratio 2022
-1.71 x
P/E ratio 2023
-5.04 x
Employees 45
Yield 2022 *
-
Yield 2023
-
Free-Float 73.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.95%
1 week-3.09%
Current month-28.79%
1 month-29.32%
3 months-68.24%
6 months-69.38%
Current year-66.43%
More quotes
1 week
9.00
Extreme 9
10.60
1 month
9.00
Extreme 9
15.00
Current year
9.00
Extreme 9
36.90
1 year
9.00
Extreme 9
52.00
3 years
9.00
Extreme 9
118.00
5 years
9.00
Extreme 9
173.90
10 years
9.00
Extreme 9
278.82
More quotes
Managers TitleAgeSince
Founder 62 07-04-22
Chief Executive Officer - 20-03-22
Director of Finance/CFO - 17-09-14
Members of the board TitleAgeSince
Director/Board Member 60 16-10-03
Director/Board Member 63 19-04-04
Chief Executive Officer - 20-03-22
More insiders
Date Price Change Volume
24-03-28 9.4 -0.95% 708,095
24-03-27 9.49 -2.16% 373,708
24-03-26 9.7 +1.04% 113,751
24-03-25 9.6 -0.83% 36,082
24-03-22 9.68 +1.47% 491,337

Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT

More quotes
Oxford BioDynamics Plc is a United Kingdom-based biotechnology company developing medicine tests for immune health based on the EpiSwitch 3D genomics platform. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch CST and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test, which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch CST is a blood test for the prediction of COVID-19 severity in any adult. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The EpiSwitch platform offers reproducibly translating 3D genome regulation for clinical application. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.
More about the company
  1. Stock
  2. Equities
  3. Stock Oxford BioDynamics Plc - London S.E.